Searched for
CDSCO DRUG BAN
Banned substance in shrimp: Vet shops under close watchIndia's top drug regulator is cracking down on veterinary shops. This action follows a significant rejection of shrimp exports to major mar...- Indian pharma firms flood west Africa with powerful opioids despite crackdown: AFP investigationIndian pharmaceutical firms are exporting millions of dollars worth of powerful tapentadol opioids to West Africa, fueling a deadly drugs e...
- ED raids seven Chennai sites linked to Sresan Pharma over Coldrif cough syrup deathsThe Enforcement Directorate (ED) conducted searches at seven locations in Chennai concerning the Coldrif cough syrup case. These raids, und...
- MP police registers FIR against Sresan Pharma, links deaths of children directly to the companyMadhya Pradesh police have registered an FIR against Sresan Pharma for allegedly adulterated Coldrif syrup, linked to the deaths of 21 chil...
- Punjab becomes latest state to ban 'Coldrif' cough syrup after 14 children die in Madhya PradeshPunjab has banned 'Coldrif' cough syrup after it was found to contain diethylene glycol at levels far exceeding the permitted limit. The sy...
- Cough syrup deaths: NHRC sends notices to Madhya Pradesh, Rajasthan, UP govts and Drugs Controller GeneralNational Human Rights Commission has issued notices to four states and the Drug Controller General following child deaths linked to cough s...
- MP bans Coldrif cough syrup sale following death of 14 children; toxic chemical found in samplesMadhya Pradesh banned Coldrif cough syrup after 14 children died in Chhindwara due to suspected renal failure. The syrup was found to conta...
- Cough syrup deaths: CDSCO launches risk-based inspection at manufacturing units of 19 drugsIndia's drug regulator, CDSCO, initiated risk-based inspections at 19 drug manufacturing units, including cough syrups, across six states f...
- Stricter shelf life rule a bitter pill to swallow for pharma companiesA new regulation by the CDSCO mandates that exported drugs must have at least 60% shelf life remaining, causing significant losses to the I...
- One nation, one check: India needs centralised drug regulation to ensure public healthCentralisation of drug regulation in India is critical to ensure consistent drug quality and safety standards nationwide. The current fragm...
- Ordered recall of drugs not meeting quality standards, action started to book 5 fake drug manufacturers: DCGIIndia's drug regulator has ordered the recall of around 45 medicines that did not meet quality norms, while action has been taken against m...
- Regulator revokes state licensors' power to issue NOC for drug exportsIndia's drug regulator withdraws state licensing authorities' NOC issuance power for export of unapproved drugs due to substandard products...
- Chemists' body urges cabinet secy to ban online pharmaciesThe chemists's body has alleged that no further action has been taken, despite notices being served on various online pharmacies by the Dru...
- Delhi High Court seeks government reply on unsafe drugs ban pleaThe three medicines -- buclizine, flupenthixol+melitracen and aceclofenac+drotavarine -- together had a market size of around Rs 67 crore f...
- No online sale of medicines till norms in place, says Delhi High CourtThe observations by the bench were made while hearing the applications moved by some online pharmacies seeking to be impleaded in the matte...
- Health Ministry bans over-the-counter sale of 14 steroid creamsThe ministry has put 14 steroid-based creams and ointments under the Schedule H category by making amendments to certain Drugs and Cosmetic...
- Health ministry to review ban on Pioglitazone tomorrowIn the wake of opposition from industry and medical fraternity to the ban on anti-diabetes drug Pioglitazone, DTAB will review the decision...
- Health Ministry bans three drugs in the countryHealth Ministry has banned the manufacture, sale and distribution of painkiller Analgin, anti-diabetes drug Pioglitazone and anti-depressan...
- Drugs banned abroad may still be of use in some cases“However, the riskbenefit ratio is context specific and dosage specific,” says Dhananjay Bakhle, executive vice-president, medical research...
- Drugs banned abroad may still be of use in some casesWhile certain drugs that are more harmful than efficacious need to be banned. However, not all drugs banned abroad need to be banned in Ind...
Load More
